Jason Cohen

About the Author Jason Cohen

Jason is a Smarter Analyst editor and writer, who specializes in biotech and cannabis-based pharmaceutical companies.

Oppenheimer Reiterates Outperform On Community Health Systems, $60 PT

In a research report released today, Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating on Community Health Systems (NYSE:CYH) with a $60, which represents …

Texas Roadhouse: We See Limited Earnings Upside, Says Oppenheimer

In a research report published today, Oppenheimer analyst Brian Bittner reiterated a Perform rating on Texas Roadhouse (NASDAQ:TXRH), following the company’s earnings results, …

Deutsche Bank Reiterates Buy On Marsh & Mclennan; $59 PT

In a research report released today, Deutsche Bank analyst Joshua Shanker reiterated a Buy rating on Marsh & Mclennan (NYSE:MMC) with a price target …

MLV Reiterates Buy On Quantum Fuel, Sees 33% Upside For The Stock

In a research report issued today, MLV analyst Carter Driscoll reiterated a Buy rating on Quantum Fuel (NASDAQ:QTWW) with a price target of …

Deutsche Bank Downgrades Lincoln National To Hold But Raises PT To $62

In a research report issued today, Deutsche Bank analyst Yaron Kinar downgraded Lincoln National (NYSE:LNC) to Hold from Buy, and raised his price …

Deutsche Bank Downgrades ITC Holdings Shares To Hold, Sees Slight Downside For The Stock

In a research report issued today, Deutsche Bank analyst Jonathan Arnold downgraded ITC Holdings Corp (NYSE:ITC) to Hold from Buy, while maintaining $38 price target, …

Deutsche Bank Initiates Buy On Shares Of Citizens Financial Group

In a research report published Monday, Deutsche Bank analyst Matt O’connor initiated Buy rating on shares of Citizens Financial Group (NYSE:CFG), while no price target was …

Deutsche Bank Questioned Barrick’s Ability To Deleverage Its Balance Sheet

In a research report released Monday, Deutsche Bank analyst Jorge Beristain downgraded shares of Barrick Gold Corp. (NYSE:ABX) to Hold from Buy and reduced his price target to $16 (from …

Oppenheimer Reiterates Outperform On Tesoro Logistics, Sees 24% Upside

Oppenheimer analyst Bernard Colson reiterated an Outperform rating on Tesoro Logistics LP (NYSE:TLLP) with a price target of $70.00, which represents a potential …

Oppenheimer Maintains Pefrom On Exxon Mobil Following 3Q14 Earnings

Oppenheimer analyst Fadel Gheit maintained a Perform rating on Exxon Mobil Corp. (NYSE:XOM), following the company’s release of its third-quarter results.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts